With the theme of “Embracing change for efficient healthcare”, HMA 2023 will showcase forward-looking hospitals that have transformed their operations to improve efficiency and quality of care. More often than not, this transformation involves the adoption of digital and smart solutions. At this year’s HMA 2023 conference, we have put together a session where top hospitals in Asia will share their experiences and case studies with using technology to supp

OSE Immunotherapeutics SA today announced that the United States Patent and Trademark Office has granted a new patent protecting Tedopi®, a therapeutic cancer vaccine treating HLA-A2 positive patients after secondary resistance to PD-1/PD-L1 immune checkpoint inhibitor treatment. The new patent further improves the unique value proposition of Tedopi® and provides protection until year 2037 in the US. This US patent recognises the innovation of a multiepitope combination (all

OSF HealthCare is an integrated health system that is owned by The Sisters of the Third Order of St Francis. Headquartered in Peoria, Illinoi, it has 15 hospitals – 10 acute care and five critical access, as well as 2,084 licensed beds and 24,000 Mission Partners in over 150 locations. "Fortune Magazine has recognised us as one of America's most innovative companies in the country for 2023 – this is a huge testament to what the organisation has invested in innov

Boehringer Ingelheim announced today that Cyltezo, a U.S. Food and Drug Administration-approved Interchangeable biosimilar to Humira, is now commercially available in the U.S. Cyltezo was initially approved as a biosimilar in 2017 for use in multiple chronic inflammatory diseases. Cyltezo was approved as an Interchangeable biosimilar in 2021, and is available as a prefilled syringe, or as a Cyltezo® Pen autoinjector. "Cyltezo is the first and only FDA-approved Interchangeab

VitaDAO, the global community accelerating research and development in longevity science, is pleased to announce the launch of the VITA-FAST tokens. This marks the first-ever opportunity for token holders to directly influence longevity research, setting a new precedent in the field of decentralized science (DeSci). The VITA-FAST tokens, which allow holders to make decisions on IP licensing, set experiment priorities, and govern research on autophagy, have been met with overwhelming

The 1,400 registered nurses of Tufts Medical Center in Boston, who are represented by the Massachusetts Nurses Association, voted overwhelmingly on Monday, June 26 to ratify their newest contract settlement. The 18-month agreement brings with it highly competitive wage increases, an extremely desirable Baylor Plan intended to help recruit nurses to work weekend shifts, and an incentive plan for nurses who commit to working 48 hours per week for 12 weeks. “Hospitals elsewhere a

PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the University of Oxford to license the Oxford Endometriosis Gene (OXEGENE) dataset with the aim to develop new personalised treatments for endometriosis patients. Endometriosis is a chronic disease associated with severe pain and infertility. It affects 10% of women globally, but how and why it develops is unknown. On average it takes over 7

Avanos Medical supports the announcement today from the UK's National Institute for Health and Care Excellence recommending the use of radiofrequency ablation for the treatment of osteoarthritic knee pain. From the NICE announcement: "Radiofrequency energy is used to denervate the target nerves. The radiofrequency energy can be delivered as conventional radiofrequency, cooled radiofrequency or pulsed radiofrequency. The aim is to reduce pain and delay the need for knee arth

Leaders from Avel eCare, the nation's leading provider of clinician-to-clinician telemedicine services, recently returned from Washington, D.C. where executives held an informational briefing session for Senate staff on an innovative telemedicine program called Virtual Crisis Care. Avel eCare's VCC program equips law enforcement with telemedicine tablets to connect officers on-demand with behavioral health professionals who can assess the situation and make informed recommen

Perfect Medical Health Management Limited one of the largest aesthetic medical operators in the world, together with its subsidiaries is pleased to announce its annual results for the year ended 31 March 2023. RESULTS HIGHLIGHTS -- The Group's revenue increased by 2.9% to HK$1,389.3 million, thanks to the better performance in recent months after the gradual relaxation of all social distancing measures in Hong Kong. -- The Group's EBITDA increased by 2.7% to HK